Skip to main content

Table 1 Age-standardized DALY rate per 100,000 population by NCDs and EEA Member States, 2019

From: Inequalities in the burden of non-communicable diseases across European countries: a systematic analysis of the Global Burden of Disease 2019 study

Cause

Austria

Belgium

Bulgaria

Croatia

Cyprus

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

NCDs

16,239

(13,738–19,152)

(100)

16,513

(13,920–19,413)

(100)

24,342

(20,406–28,775)

(100)

17,974

(14,981–21,351)

(100)

16,599

(14,057–19,448)

(100)

CVDs

2,408

(2,225–2,552)

(14.8)

2,021

(1,879–2,144)

(12.2)

9,570

(7,964–11,490)

(39.3)

4,267

(3,532–5,131)

(23.7)

2,939

(2,629–3,303)

(17.7)

Chronic respiratory diseases

651

(544–777)

(4.0)

879

(763–1,012)

(5.3)

693

(576–819)

(2.8)

632

(524–748)

(3.5)

864

(707–1,028)

(5.2)

Diabetes and kidney diseases

790

(654–953)

(4.9)

694

(548–873)

(4.2)

1,265

(1,039–1,516)

(5.2)

981

(775–1,229)

(5.5)

1,165

(972–1,388)

(7.0)

Digestive diseases

674

(595–768)

(4.1)

641

(580–714)

(3.9)

1,282

(1,045–1,554)

(5.3)

898

(731–1,083)

(5.0)

483

(423–555)

(2.9)

Mental disorders

1,905

(1,388–2,518)

(11.7)

1,875

(1,369–2,467)

(11.4)

1,349

(991–1,785)

(5.5)

1,451

(1,059–1,919)

(8.1)

1,915

(1,390–2,541)

(11.5)

Musculoskeletal disorders

1,971

(1,413–2,650)

(12.1)

2,042

(1,461–2,729)

(12.4)

1,544

(1,096–2,061)

(6.3)

1,600

(1,141–2,117)

(8.9)

2,225

(1,597–2,963)

(13.4)

Neoplasms

2,820

(2,682–2,968)

(17.4)

3,256

(3,096–3,421)

(19.7)

4,368

(3,485–5,458)

(17.9)

3,770

(2,989–4,719)

(21.0)

2,648

(2,366–2,944)

(16.0)

Neurological disorders

1,326

(734–2,203)

(8.2)

1,579

(775–2,769)

(9.6)

1,313

(784–2,066)

(5.4)

1,289

(732–2,047)

(7.2)

1,330

(690–2,273)

(8.0)

Sense organ diseases

392

(263–558)

(2.4)

409

(279–580)

(2.5)

618

(412–888)

(2.5)

606

(407–879)

(3.4)

397

(268–569)

(2.4)

Skin and subcutaneous diseases

711

(482–1,013)

(4.4)

730

(504–1,024)

(4.4)

454

(300–669)

(1.9)

444

(293–654)

(2.5)

719

(500–1,021)

(4.3)

Substance use disorders

659

(516–816)

(4.1)

601

(476–750)

(3.6)

384

(291–497)

(1.6)

523

(406–660)

(2.9)

358

(267–461)

(2.2)

Other NCDs

1,932

(1,486–2,487)

(11.9)

1,788

(1,348–2,322)

(10.8)

1,503

(1,189–1,904)

(6.2)

1,513

(1,157–1,950)

(8.4)

1,556

(1,184–2,026)

(9.4)

Cause

Czechia

Denmark

Estonia

Finland

France

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

NCDs

17,125

(14,441–20,203)

(100)

17,166

(14,672–19,955)

(100)

18,874

(15,777–22,305)

(100)

16,428

(13,963–19,205)

(100)

15,461

(13,059–18,230)

(100)

CVDs

3,909

(3,314–4,605)

(22.8)

1,968

(1,833–2,091)

(11.5)

4,651

(3,813–5,715)

(24.6)

2,864

(2,653–3,031)

(17.4)

1,628

(1,489–1,742)

(10.5)

Chronic respiratory diseases

628

(529–728)

(3.7)

1030

(867–1,167)

(6.0)

354

(294–426)

(1.9)

618

(512–756)

(3.8)

554

(445–692)

(3.6)

Diabetes and kidney diseases

1,251

(960–1,590)

(7.3)

678

(576–798)

(4.0)

752

(600–928)

(4.0)

685

(512–889)

(4.2)

463

(383–558)

(3.0)

Digestive diseases

896

(748–1,062)

(5.2)

686

(616–768)

(4.0)

987

(805–1,203)

(5.2)

788

(717–873)

(4.8)

565

(512–629)

(3.7)

Mental disorders

1,385

(1,014–1,825)

(8.1)

1,794

(1,303–2,376)

(10.5)

1,573

(1,145–2,081)

(8.3)

1,887

(1,387–2,497)

(11.5)

2,045

(1,489–2,717)

(13.2)

Musculoskeletal disorders

1,548

(1,110–2,065)

(9.0)

2,485

(1,781–3,292)

(14.5)

1,510

(1,080–2,011)

(8.0)

2,037

(1,467–2,717)

(12.4)

2,055

(1,474–2,732)

(13.3)

Neoplasms

3,405

(2,813–4,137)

(19.9)

3,494

(3,304–3,675)

(20.4)

3,522

(2,774–4,417)

(18.7)

2,606

(2,442–2,778)

(15.9)

3,311

(3,133–3,473)

(21.4)

Neurological disorders

1,269

(725–2,038)

(7.4)

1,282

(712–2,110)

(7.5)

1,337

(810–2,094)

(7.1)

1,396

(763–2,301)

(8.5)

1,426

(791–2,290)

(9.2)

Sense organ diseases

595

(398–861)

(3.5)

374

(250–537)

(2.2)

642

(427–932)

(3.4)

388

(262–553)

(2.4)

402

(273–572)

(2.6)

Skin and subcutaneous diseases

454

(300–669)

(2.7)

776

(529–1,106)

(4.5)

553

(357–805)

(2.9)

748

(515–1,058)

(4.6)

843

(578–1,180)

(5.5)

Substance use disorders

515

(398–648)

(3.0)

890

(743–1,052)

(5.2)

1,646

(1,350–1,989)

(8.7)

925

(785–1,079)

(5.6)

567

(453–697)

(3.7)

Other NCDs

1,271

(947–1,677)

(7.4)

1,709

(1,290–2,218)

(10.0)

1,345

(1,009–1,758)

(7.1)

1,484

(1,114–1,945)

(9.0)

1,602

(1,228–2,056)

(10.4)

Cause

Germany

Greece

Hungary

Iceland

Ireland

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

NCDs

17,277

(14,710–20,233)

(100)

17,222

(14,700–20,068)

(100)

20,458

(17,350–23,915)

(100)

14,845

(12,379–17,682)

(100)

16,792

(14,166–19,735)

(100)

CVDs

2,601

(2,422–2,741)

(100)

3,198

(3,001–3,351)

(18.6)

5,420

(4,612–6,359)

(26.5)

1,853

(1,669–2,032)

(12.5)

2,193

(1,990–2,338)

(13.1)

Chronic respiratory diseases

749

(651–857)

(15.1)

724

(611–843)

(4.2)

947

(816–1,099)

(4.6)

768

(635–936)

(5.2)

969

(830–1,128)

(5.8)

Diabetes and kidney diseases

894

(723–1,099)

(4.3)

790

(638–967)

(4.6)

1,020

(815–1,254)

(5.0)

533

(408–683)

(3.6)

622

(491–770)

(3.7)

Digestive diseases

742

(677–816)

(5.2)

470

(412–548)

(2.7)

1,269

(1,063–1,489)

(6.2)

355

(305–411)

(2.4)

465

(413–533)

(2.8)

Mental disorders

1,899

(1,368–2,515)

(4.3)

2,260

(1,664–2,968)

(13.1)

1,394

(1,014–1,851)

(6.8)

1,761

(1,283–2,342)

(11.9)

2,202

(1,612–2,884)

(13.1)

Musculoskeletal disorders

2,211

(1,583–2,927)

(11.0)

2,031

(1,463–2,694)

(11.8)

1,605

(1,149–2,135)

(7.8)

2,253

(1,593–3,017)

(15.2)

2,273

(1,644–3,028)

(13.5)

Neoplasms

3,221

(3,063–3,368)

(12.8)

3,300

(3,134–3,471)

(19.2)

4,551

(3,772–5,494)

(22.2)

2,690

(2,449–2,963)

(18.1)

3,049

(2,859–3,244)

(18.2)

Neurological disorders

1,539

(811–2,545)

(18.6)

1,330

(662–2,277)

(7.7)

1,260

(729–2,007)

(6.2)

1,385

(749–2,286)

(9.3)

1,404

(766–2,318)

(8.4)

Sense organ diseases

393

(267–559)

(8.9)

419

(285–594)

(2.4)

614

(412–885)

(3.0)

399

(269–570)

(2.7)

397

(269–569)

(2.4)

Skin and subcutaneous diseases

717

(485–1,039)

(2.3)

677

(465–970)

(3.9)

489

(324–716)

(2.4)

753

(515–1,064)

(5.1)

728

(500–1,031)

(4.3)

Substance use disorders

618

(501–751)

(4.1)

432

(333–540)

(2.5)

490

(378–619)

(2.4)

672

(544–822)

(4.5)

824

(654–1,007)

(4.9)

Other NCDs

1,692

(1,287–2,189)

(3.6)

1,591

(1,221–2,077)

(9.2)

1,399

(1,084–1,781)

(6.8)

1,423

(1,052–1,872)

(9.6)

1,666

(1,283–2,137)

(9.9)

Cause

Italy

Latvia

Lithuania

Luxembourg

Malta

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

NCDs

15,753

(13,159–18,646)

(100)

20,566

(17,662–23,817)

(100)

20,070

(17,138–23,241)

(100)

15,740

(13,161–18,606)

(100)

15,953

(13,411–18,839)

(100)

CVDs

2,032

(1,854–2,156)

(12.9)

6,603

(5,695–7,727)

(32.1)

5,824

(4,926–6,939)

(29.0)

1,981

(1,766–2,213)

(12.6)

2,511

(2,256–2,770)

(15.7)

Chronic respiratory diseases

539

(454–635)

(3.4)

391

(320–484)

(1.9)

424

(353–510)

(2.1)

787

(653–953)

(5.0)

674

(547–828)

(4.2)

Diabetes and kidney diseases

814

(658–992)

(5.2)

746

(600–923)

(3.6)

547

(434–683)

(2.7)

804

(618–1,020)

(5.1)

919

(744–1,129)

(5.8)

Digestive diseases

644

(553–752)

(4.1)

1,069

(903–1,256)

(5.2)

1,447

(1,215–1,729)

(7.2)

610

(531–700)

(3.9)

429

(371–495)

(2.7)

Mental disorders

1,954

(1,434–2,586)

(12.4)

1,614

(1,184–2,122)

(7.8)

1,716

(1,256–2,262)

(8.6)

1,850

(1,352–2,442)

(11.8)

1,903

(1,387–2,522)

(11.9)

Musculoskeletal disorders

2,184

(1,562–2,889)

(13.9)

1,531

(1,097–2,054)

(7.4)

1,496

(1,065–1,988)

(7.5)

2,141

(1,538–2,848)

(13.6)

2,224

(1,600–2,953)

(13.9)

Neoplasms

2,976

(2,823–3,081)

(18.9)

3,631

(3,056–4,324)

(17.7)

3,573

(2,929–4,312)

(17.8)

2,933

(2,618–3,306)

(18.6)

2,604

(2,358–2,889)

(16.3)

Neurological disorders

1,472

(740–2,567)

(9.3)

1,260

(758–1,994)

(6.1)

1,242

(748–1,967)

(6.2)

1,366

(753–2,213)

(8.7)

1,329

(711–2,222)

(8.3)

Sense organ diseases

530

(367–733)

(3.4)

691

(465–989)

(3.4)

688

(463–989)

(3.4)

380

(253–547)

(2.4)

405

(274–576)

(2.5)

Skin and subcutaneous diseases

733

(497–1,050)

(4.7)

419

(286–615)

(2.0)

441

(296–648)

(2.2)

728

(501–1,039)

(4.6)

748

(528–1,028)

(4.7)

Substance use disorders

344

(255–445)

(2.2)

1,056

(864–1,267)

(5.1)

1,053

(879–1,242)

(5.2)

664

(530–820)

(4.2)

466

(360–591)

(2.9)

Other NCDs

1,532

(1,156–1,999)

(9.7)

1,554

(1,192–1,986)

(7.6)

1,619

(1,242–2,073)

(8.1)

1,496

(1,108–1,976)

(9.5)

1,740

(1,350–2,224)

(10.9)

Cause

Netherlands

Norway

Poland

Portugal

Romania

  

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

NCDs

16,215

(13,797–19,002)

(100)

15,642

(13,123–18,527)

(100)

18,313

(15,640–21,393)

(100)

16,664

(14,085–19,599)

(100)

20,643

(17,686–23,857)

(100)

CVDs

1,883

(1,737–2,009)

(11.6)

1,901

(1,747–2,027)

(12.2)

4,183

(3,595–4,832)

(22.8)

2,150

(1,997–2,282)

(100)

6,644

(5,673–7,840)

(32.2)

Chronic respiratory diseases

977

(816–1,136)

(6.0)

889

(719–1,049)

(5.7)

651

(541–783)

(3.6)

861

(706–1,064)

(12.9)

714

(602–851)

(3.5)

Diabetes and kidney diseases

637

(519–775)

(3.9)

650

(516–807)

(4.2)

951

(752–1,160)

(5.2)

980

(798–1,199)

(5.2)

781

(629–961)

(3.8)

Digestive diseases

438

(394–491)

(2.7)

510

(431–606)

(3.3)

1,033

(874–1,211)

(5.6)

624

(571–690)

(5.9)

1,501

(1,269–1,782)

(7.3)

Mental disorders

2,069

(1,519–2,734)

(12.8)

1,945

(1,427–2,580)

(12.4)

1,259

(930–1,651)

(6.9)

2,317

(1,672–3,082)

(3.7)

1,368

(1,007–1,805)

(6.6)

Musculoskeletal disorders

2,001

(1,435–2,655)

(12.3)

1,879

(1,333–2,519)

(12.0)

1,629

(1,167–2,169)

(8.9)

2,256

(1,628–2,974)

(13.9)

1,579

(1,122–2,113)

(7.6)

Neoplasms

3,614

(3,411–3,796)

(22.3)

2,844

(2,705–2,968)

(18.2)

4,192

(3,527–4,913)

(22.9)

3,135

(2,980–3,302)

(13.5)

3,998

(3,275–4,799)

(19.4)

Neurological disorders

1,414

(787–2,320)

(8.7)

1,474

(794–2,439)

(9.4)

1,337

(800–2,121)

(7.3)

1,291

(668–2,200)

(18.8)

1,249

(703–2,034)

(6.1)

Sense organ diseases

371

(249–538)

(2.3)

470

(317–664)

(3.0)

637

(431–912)

(3.5)

413

(283–589)

(7.7)

623

(416–896)

(3.0)

Skin and subcutaneous diseases

721

(497–1,019)

(4.4)

716

(484–1,022)

(4.6)

460

(307–676)

(2.5)

733

(504–1,038)

(2.5)

421

(281–624)

(2.0)

Substance use disorders

428

(325–538)

(2.6)

668

(555–790)

(4.3)

765

(609–934)

(4.2)

477

(344–634)

(4.4)

361

(274–463)

(1.7)

Other NCDs

1,663

(1,263–2,132)

(10.3)

1,697

(1,271–2,213)

(10.9)

1,216

(941–1,582)

(6.6)

1,428

(1,086–1,855)

(2.9)

1,405

(1,087–1,811)

(6.8)

Cause

Slovakia

Slovenia

Spain

Sweden

United Kingdom

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

DALY rate

95%UI

(%)

NCDs

18,755

(15,624–22,338)

(100)

15,164

(12,511–18,272)

(100)

15,454

(13,046–18,341)

(100)

15,351

(12,978–18,096)

(100)

18,001

(15,317–21,079)

(100)

CVDs

5,134

(4,207–6,179)

(27.4)

2,546

(2,068–3,143)

(16.8)

1,834

(1,699–1,958)

(11.9)

2,329

(2,149–2,483)

15.2)

2,362

(2,216–2,477)

(13.1)

Chronic respiratory diseases

476

(395–569)

(2.5)

505

(407–613)

(3.3)

752

(649–863)

(4.9)

786

(634–963)

(5.1)

1,187

(1,004–1,392)

(6.6)

Diabetes and kidney diseases

848

(666–1,049)

(4.5)

697

(516–888)

(4.6)

789

(608–999)

(5.1)

615

(502–746)

(4.0)

780

(592–993)

(4.3)

Digestive diseases

1,242

(996–1,555)

(6.6)

864

(697–1,078)

(5.7)

551

(500–614)

(3.6)

466

(410–535)

(3.0)

889

(794–1,008)

(4.9)

Mental disorders

1,373

(1,015–1,817)

(7.3)

1,462

(1,071–1,929)

(9.6)

2,192

(1,614–2,905)

(14.2)

2,017

(1,474–2,653)

(13.1)

1,959

(1,437–2,590)

(10.9)

Musculoskeletal disorders

1,541

(1,099–2,049)

(8.2)

1,521

(1,081–2,033)

(10.0)

1,831

(1,298–2,442)

(11.8)

2,036

(1,472–2,692)

(13.3)

2,314

(1,671–3,050)

(12.9)

Neoplasms

3,762

(2,974–4,712)

(20.1)

3,341

(2,615–4,278)

(22.0)

2,977

(2,820–3,120)

(19.3)

2,672

(2,550–2,783)

(17.4)

3,302

(3,164–3,403)

(18.3)

Neurological disorders

1,281

(739–2,049)

(6.8)

1,249

(727–2,025)

(8.2)

1,350

(700–2,272)

(8.7)

1,321

(692–2,210)

(8.6)

1,434

(826–2,318)

(8.0)

Sense organ diseases

606

(400–878)

(3.2)

568

(377–825)

(3.7)

538

(370–749)

(3.5)

340

(227–487)

(2.2)

503

(342–711)

(2.8)

Skin and subcutaneous diseases

451

(296–662)

(2.4)

451

(297–665)

(3.0)

698

(481–986)

(4.5)

692

(469–985)

(4.5)

736

(505–1,043)

(4.1)

Substance use disorders

477

(356–616)

(2.5)

621

(490–775)

(4.1)

469

(354–605)

(3.0)

692

(569–818)

(4.5)

924

(730–1,136)

(5.1)

Other NCDs

1,564

(1,204–2,023)

(8.3)

1,337

(997–1,772)

(8.8)

1,472

(1,129–1,900)

(9.5)

1,386

(1,048–1,799)

(9.0)

1,609

(1,254–2,037)

(8.9)

  1. Legend: % percentage, UI Uncertainty Interval, NCDs noncommunicable diseases, and CVDs cardiovascular diseases